CoChat

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations

Open access
Hauser, Kevin, Negron, Christopher, Albanese, Steven K., Ray, Soumya, Steinbrecher, Thomas, Abel, Robert, Chodera, John D., Wang, Lingle · 2018 · Communications Biology
Cited by 94

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

The therapeutic effect of targeted kinase inhibitors can be significantly reduced by intrinsic or acquired resistance mutations that modulate the affinity of the drug for the kinase. In cancer, the majority of missense mutations are rare, making it difficult to predict their impact on inhibitor affinity. We examine the potential for alchemical free-energy calculations to predict how kinase mutations modulate inhibitor affinities to Abl, a major target in chronic myelogenous leukemia (CML). These calculations have useful accuracy in predicting resistance for eight FDA-approved kinase inhibitors across 144 clinically identified point mutations, with a root mean square error in binding free-energy changes of $$1.1_{0.9}^{1.3}$$ 1 . 1 0.9 1.3 kcal mol −1 (95% confidence interval) and correctly classifying mutations as resistant or susceptible with $$88_{82}^{93}$$ 8 8 82 93 % accuracy. This benchmark establishes the potential for physical modeling to collaboratively support the assessment and anticipation of patient mutations to affect drug potency in clinical applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-018-0075-x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 94

Metadata

Authors
Hauser, K., Negron, C., Albanese, S. K., Ray, S., Steinbrecher, T., Abel, R., Chodera, J. D., & Wang, L.
Venue
Communications Biology
Published
2018-06-13
Volume
1
Issue
1
Pages
70-70
ISSN
2399-3642 (ISSN-L)
OpenAlex
W2951718918
Cited by
94
References
15
FWCI
7.28
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations. https://app.cochat.ai/papers/10.1038/s42003-018-0075-x
The paper
Hauser, K., Negron, C., Albanese, S. K., Ray, S., Steinbrecher, T., Abel, R., Chodera, J. D., & Wang, L. (2018). Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations. Communications Biology. https://doi.org/10.1038/s42003-018-0075-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.